Free Newsletter
Sens. would dispatch pharma anti-reps
Should the feds send out their own pharma reps? Wednesday, the Senate Special Committee on Aging will convene to discuss "academic detailing," which is essentially a straight talk express for pharma. Special reps fan out with their own--presumably objective--educational materials to help counteract the naturally biased info each drug company provides on its own products. Some states are doing it with mixed results; some critics say these so-called straight talkers actually are trying to push generics over brand-name meds even when newer meds are better.
Sen. Herb Kohl, who chairs the committee, and Sen. Dick Durbin plan to sponsor a bill this spring that would create a federal corps of academic detailers. "The industry's educational outreach is essentially a marketing program, and evidence shows that doctors' prescribing patterns can be heavily influenced," the committee's statement about the hearing said. An academic detailing program would give docs and other prescribers a source of unbiased info "based on scientific research."
- see the Pharmalot item
- check out the back-story on Pennsylvania's academic detailing program
Related Articles:
States fight drug reps with reps. Report
Dr. Drug Rep tells all. Report
Rep decries off-label marketing "loophole." Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: